XML 35 R27.htm IDEA: XBRL DOCUMENT
v3.23.4

EQUITY | 6 Months Ended
--- | ---
Jun. 30, 2023
Equity |
EQUITY |
| 19. | EQUITY
| (a) | Issued capital
Schedule of issued capital |  |  |  |  |  |  |  |  |
|  | December 31, |  |  | June 30, |
|  | 2022 |  |  | 2023 |  |  | 2023 |
|  | CNY |  |  | CNY |  |  | US$ |
|  | (Audited) |  |  | (Unaudited) |  |  | (Unaudited) |
Authorized: |  |  |  |  |  |  |  |  |  |  |  |
10,000,000 preferred shares, no par value |  |  | — |  |  |  | — |  |  |  | — |
200,000,000 common shares, no par value |  |  | — |  |  |  | — |  |  |  | — |
Common shares issued and fully paid: |  |  |  |  |  |  |  |  |  |  |  |
June 30, 2023: 8,197,897*, (December 31, 2022: 40,948,082) common shares, no par value |  |  | 450,782 |  |  |  | 450,782 |  |  |  | 62,146 |
Schedule of share capital |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of shares |  |  | Share capital |
|  |  |  |  | CNY |  |  | US$ |
As of January 1, 2022 |  |  | 40,948,082 |  |  |  | 450,782 |  |  |  | 62,146 |
Common shares issued through private placement |  |  | — |  |  |  | — |  |  |  | — |
As of December 31, 2022 and January 1, 2023 |  |  | 40,948,082 |  |  |  | 450,782 |  |  |  | 62,146 |
Effect of Five-to-One Share Combination* |  |  | (32,750,185 | ) |  |  | — |  |  |  | — |
As of June 30, 2023 |  |  | 8,197,897 |  |  |  | 450,782 |  |  |  | 62,146 |
* | On April 3, 2023, the Company effected a share combination in which all of the Company's issued and outstanding ordinary shares were combined on a 5-to-1 basis. The basic and diluted earnings/(loss) per ordinary share has been retrospectively adjusted to reflect the impact of the share combination. All outstanding options, warrants and other rights to purchase the Company's common shares were adjusted proportionately as a result of the share combination.
| (b) | Other capital reserves
Other capital reserves of the Company are mainly for equity-settled share-based compensation, the exercise of stock options, the exercise of warrants, the business combination and the deemed contribution from the Shareholder of the Company and related companies.

X
- References No definition available. + Details
Name: | chnr_DisclosureEquityAbstract
Namespace Prefix: | chnr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | chnr_EquityExplanatory
Namespace Prefix: | chnr_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration